Douglas A. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Douglas A. Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Andleeb Khan
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
2 shared publicationsMoisés A. Arriaga
Department of Otolaryngology, Baton Rouge, Louisiana
2 shared publicationsTodd A. Hillman
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
2 shared publicationsDavid M. Souza
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publicationFarrel J. Buchinsky
Division of Otolaryngology, Philadelphia, Pennsylvania
1 shared publicationKellen J. Stromberg
Department of Otolaryngology, Temple University, Philadelphia, Pennsylvania
1 shared publication
Latest Publications
- 19 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 203-208
Long‐term outcomes of cartilage‐buttressed T‐tube tympanoplasty for prolonged middle ear ventilation
Objectives/Hypothesis: To report on the safety and efficacy of cartilage‐buttressed T‐tube tympanoplasty for long‐term middle ear ventilation, specifically by examining duration of tube survival, as well as adverse events associated with prolonged middle ear intubation, including persistent tympanic membrane perforation.Study Design: Retrospective case series of patients undergoing cartilage‐buttressed T‐tube tympanoplasty between January 2005 and December 2016 in a tertiary‐care neurotology private practice.Methods: Patients who underwent cartilage T‐tube tympanoplasty with complete pre‐ and postoperative audiometric data and a minimum follow‐up duration of 12 months were analyzed. T‐tube survival and adverse events including persistent tympanic membrane perforation were recorded and compared to published data for other long‐term middle ear ventilation techniques.Results: The study cohort included 72 cartilage‐buttressed T‐tube tympanoplasties in 68 patients. Median tube survival was 34 months (range, 2–131 months). Incidence of persistent tympanic membrane perforation (n = 1) was 1.4%Conclusions: Cartilage‐buttressed T‐tube tympanoplasty is a safe and effective means of accomplishing long‐term middle ear ventilation with a considerably lower rate of persistent tympanic membrane perforation as compared to alternative methods of prolonged middle ear ventilation.Level of Evidence: 4 Laryngoscope, 129:203–208, 2019
- 19 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 203-208
Long‐term outcomes of cartilage‐buttressed T‐tube tympanoplasty for prolonged middle ear ventilation
Objectives/Hypothesis: To report on the safety and efficacy of cartilage‐buttressed T‐tube tympanoplasty for long‐term middle ear ventilation, specifically by examining duration of tube survival, as well as adverse events associated with prolonged middle ear intubation, including persistent tympanic membrane perforation.Study Design: Retrospective case series of patients undergoing cartilage‐buttressed T‐tube tympanoplasty between January 2005 and December 2016 in a tertiary‐care neurotology private practice.Methods: Patients who underwent cartilage T‐tube tympanoplasty with complete pre‐ and postoperative audiometric data and a minimum follow‐up duration of 12 months were analyzed. T‐tube survival and adverse events including persistent tympanic membrane perforation were recorded and compared to published data for other long‐term middle ear ventilation techniques.Results: The study cohort included 72 cartilage‐buttressed T‐tube tympanoplasties in 68 patients. Median tube survival was 34 months (range, 2–131 months). Incidence of persistent tympanic membrane perforation (n = 1) was 1.4%Conclusions: Cartilage‐buttressed T‐tube tympanoplasty is a safe and effective means of accomplishing long‐term middle ear ventilation with a considerably lower rate of persistent tympanic membrane perforation as compared to alternative methods of prolonged middle ear ventilation.Level of Evidence: 4 Laryngoscope, 129:203–208, 2019
- 6 January 2017
- Published by Wiley in The Laryngoscope
- Vol. 127 (9) , 2120-2125
Hydroxyapatite cement cranioplasty following translabyrinthine approach: Long‐term study of 369 cases
Objective: To report the authors' experience with hydroxyapatite cement (HAC) cranioplasty and analyze the material's long‐term safety and efficacy in repairing translabyrinthine skull‐base defects by examining adverse events, specifically cerebrospinal fluid (CSF) leaks and surgical site infections.Study Design: Retrospective case‐control study (primary study arm); prospective cross‐sectional study of patients not examined within the last 5 years (secondary arm). Setting: tertiary‐care neurotology private practice and academic practice (two centers).Methods: Hydroxyapatite cement implanted following translabyrinthine approach, with or without fat graft, was included. Combined approaches were excluded. Implant‐associated adverse events were defined as 1) CSF leaks requiring reoperation or spinal drainage, and (2) infections requiring reoperation. Patients not examined within 5 years were interviewed by telephone to update their condition. Incidence of adverse events was compared to published data for translabyrinthine cranioplasty using fat graft alone. Implant survival analysis was performed.Results: The study cohort included 369 HAC implants in the same number of patients. There were seven CSF leaks and seven infections. Combined (n = 14) incidence of adverse events was 3.8% (2.09%, 6.28%). Compared to fat graft alone, the adverse events associated with HAC were fewer (P < 0.001). Up to 15 years (5,475 days), HAC cement maintained 95% adverse event‐free survival. There were no cases of meningitis.Conclusion: Cranioplasty using HAC with autologous fat following translabyrinthine skull‐base surgery is safer and more effective than fat graft alone, up to 15 years after surgery.Level of Evidence: 4. Laryngoscope, 127:2120–2125, 2017
- 6 January 2017
- Published by Wiley in The Laryngoscope
- Vol. 127 (9) , 2120-2125
Hydroxyapatite cement cranioplasty following translabyrinthine approach: Long‐term study of 369 cases
Objective: To report the authors' experience with hydroxyapatite cement (HAC) cranioplasty and analyze the material's long‐term safety and efficacy in repairing translabyrinthine skull‐base defects by examining adverse events, specifically cerebrospinal fluid (CSF) leaks and surgical site infections.Study Design: Retrospective case‐control study (primary study arm); prospective cross‐sectional study of patients not examined within the last 5 years (secondary arm). Setting: tertiary‐care neurotology private practice and academic practice (two centers).Methods: Hydroxyapatite cement implanted following translabyrinthine approach, with or without fat graft, was included. Combined approaches were excluded. Implant‐associated adverse events were defined as 1) CSF leaks requiring reoperation or spinal drainage, and (2) infections requiring reoperation. Patients not examined within 5 years were interviewed by telephone to update their condition. Incidence of adverse events was compared to published data for translabyrinthine cranioplasty using fat graft alone. Implant survival analysis was performed.Results: The study cohort included 369 HAC implants in the same number of patients. There were seven CSF leaks and seven infections. Combined (n = 14) incidence of adverse events was 3.8% (2.09%, 6.28%). Compared to fat graft alone, the adverse events associated with HAC were fewer (P < 0.001). Up to 15 years (5,475 days), HAC cement maintained 95% adverse event‐free survival. There were no cases of meningitis.Conclusion: Cranioplasty using HAC with autologous fat following translabyrinthine skull‐base surgery is safer and more effective than fat graft alone, up to 15 years after surgery.Level of Evidence: 4. Laryngoscope, 127:2120–2125, 2017
- 1 December 2014
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 47 (6) , 927-939
Vibrant Soundbridge Rehabilitation of Sensorineural Hearing Loss
- 1 December 2014
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 47 (6) , 927-939
Vibrant Soundbridge Rehabilitation of Sensorineural Hearing Loss
- 1 July 1997
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 19 (14)
Vestibular Nerve Section in the Treatment of Vertigo
- 1 July 1997
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 19 (14)
Vestibular Nerve Section in the Treatment of Vertigo